| Literature DB >> 36123672 |
Adeodatus Yuda Handaya1, Joshua Andrew2, Ahmad Shafa Hanif2, Kevin Radinal Tjendra2, Azriel Farrel Kresna Aditya2.
Abstract
BACKGROUND: Mini laparotomy cholecystectomy (MLC) is an alternative surgical procedure in conditions where laparoscopic cholecystectomy (LC) is not feasible. MLC is a simpler and easier technique compared to LC. MLC involves smaller skin incision, low morbidity rate, and early return to oral diet. MLC has the potential to be the preferred surgical technique in developing countries due to its low cost and availability.Entities:
Keywords: Cholecystitis; Cholelithiasis; Conversion surgery; Mini-laparotomy cholecystectomy; Predictors of conversion
Mesh:
Substances:
Year: 2022 PMID: 36123672 PMCID: PMC9484225 DOI: 10.1186/s12893-022-01792-9
Source DB: PubMed Journal: BMC Surg ISSN: 1471-2482 Impact factor: 2.030
Fig. 1Post operative wound after mini-laparotomy cholecystectomy. a On a normal weight patient. b on an obese patient
Fig. 2Side by side comparison of the size of dissected gallbladder and the mini-laparotomy incision. a gallbladder without inflammation. b gallbladder with inflammation
Fig. 3Instruments used in mini-laparotomy cholecystectomy. a1 Modified Molt dental mouth gag with the prong tip length 5 cm. a2 Modified Langenbeck retractor with shaft length of 26 cm blade length of 10 cm. a3 Hem-O-Lok clips and applicator for open surgery. (a4) right angle forceps. a5 ruler for size measurement. b Operating surgeon wearing head lamp
Subjects’ characteristics in categorical variables
| Variables | No Conversion (n = 31) [70.5%] | Conversion (n = 13) [29.5%] | All Subjects (n = 44) [100%] |
|---|---|---|---|
| Sex | |||
| Male | 8 (18.2%) | 6 (13.6%) | 14 (31.8%) |
| Female | 23 (52.3%) | 7 (15.9%) | 30 (68.2%) |
| Cholecystitis Clinical Manifestation | |||
| None | 13 (29.5%) | 3 (6.8%) | 16 (36.4%) |
| Present | 18 (40.9%) | 10 (22.7%) | 28 (63.6%) |
| USG Cholecystitis Findings | |||
| None | 23 (52.3%) | 0 | 23 (52.3%) |
| Present | 8 (18.2%) | 13 (29.5%) | 21 (47.7%) |
| Cholelithiasis | |||
| None | 0 | 0 | 0 |
| Single stone | 11 (25.0%) | 5 (11.4%) | 16 (36.4%) |
| Multiple stones | 20 (45.5%) | 8 (18.2%) | 28 (63.6%) |
| Adhesion | |||
| None | 24 (54.5%) | 1 (2.3%) | 25 (56.8%) |
| < 50% adhesion | 7 (15.9%) | 4 (9.1%) | 11 (25.0%) |
| 50–100% adhesion | 0 | 5 (11.4%) | 5 (11.4%) |
| Completely buried gallbladder | 0 | 3 (6.8%) | 3 (6.8%) |
| Microscopic findings | |||
| Normal | 0 | 0 | 0 |
| Acute inflammation | 30 (68.2%) | 5 (11.4%) | 35 (79.5%) |
| Chronic inflammation | 1 (2.3%) | 8 (18.2%) | 9 (20.5%) |
Subjects’ characteristics in numeric variables and comparison results
| Variables | All Subjects (n = 44) | No Conversion (n = 31) | Conversion (n = 13) | P—Value | |||
|---|---|---|---|---|---|---|---|
| Mean | Std. Dev | Mean | Std. Dev | Mean | Std. Dev | ||
| Independent Sample T-Test | |||||||
| Age (years) | 49.57 (26–76) | 14.09 | 48.16 (26–76) | 15.42 | 52.92 (33–67) | 9.96 | 0.312 |
| BMI | 25.31 (15.03–40.40) | 5.34 | 24.16 (15.03–40.40) | 5.16 | 28.05 (21.26–38.44) | 4.90 | 0.026** |
| Hemoglobin Level (g/dL) | 12.93 (9.9–16.7) | 1.35 | 12.90 (9.9–16.7) | 1.48 | 12.99 (11.5–14.6) | 1.04 | 0.852 |
| Leucocytes Count (× 109/L) | 8.66 (3.70–15.60) | 2.84 | 7.78 (3.70–13.20) | 2.16 | 10.75 (6.40–15.60) | 3.23 | 0.001** |
| Indirect Bilirubin (mg/dL) | 0.46 (0.08–1.10) | 0.21 | 0.41 (0.1–0.7) | 0.17 | 0.59 (0.08–1.10) | 0.25 | 0.008** |
| Mann Whitney U Test | |||||||
| Neutrophil—Lymphocyte Ratio* | 3.34 (0.95–21.44) | 3.79 | 2.29 (0.95–8.06) | 1.25 | 5.85 (1.71–21.44) | 6.17 | 0.052 |
| AST / SGOT* (U/L) | 20.57 (6–46) | 7.99 | 20.84 (6–46) | 8.50 | 19.92 (12–35) | 6.89 | 0.651 |
| ALT / SGPT* (U/L) | 27.49 (11–96) | 20.09 | 28.31 (11.0–96.0) | 20.77 | 25.54 (12–76) | 19.03 | 0.303 |
| Total Bilirubin* (mg/dL) | 0.81 (0.3–2.2) | 0.34 | 0.72 (0.3–1.2) | 0.26 | 1.02 (0.6–2.2) | 0.42 | 0.015** |
| Direct Bilirubin* (mg/dL) | 0.36 (0.1–1.1) | 0.19 | 0.32 (0.1–0.7) | 0.18 | 0.43 (0.20–1.10) | 0.23 | 0.049** |
| Adhesion | 0.000** | ||||||
| Gall Bladder Stone Count | 0.853 | ||||||
| Post-Surgery Hospitalization* (days) | 2.43 (2–5) | 0.73 | 2.10 (2–3) | 0.30 | 3.23 (2–5) | 0.83 | 0.000** |
| Surgery Duration (minutes)* | 42.61 (20–75) | 38.87 (20–75) | 10.22 | 51.54 (30–70) | 10.87 | 0.001** | |
| Chi Square Test | |||||||
| Gender | 0.166 | ||||||
| Cholecystitis Clinical Manifestation | 0.201 | ||||||
| USG Cholecystitis Findings | 0.000** | ||||||
| Microscopic Findings | 0.000** | ||||||
*Data not normally distributed, Kruskal Wallis Test
**P-value < 0.05
Evaluation of patient’s satisfaction towards the mini-laparotomy cholecystectomy using Likert Scale Questionnaire. 5-point Likert scale: (1) Strongly dissatisfied; (2) Dissatisfied; (3) Neutral; (4) Satisfied; (5) Very satisfied
| Patient’s satisfaction towards mini-laparotomy cholecystectomy | Likert Score | ||
|---|---|---|---|
| Mean | Std. Dev | ||
| Incision | Size of post-operative wound | 4.39 | 0.72 |
| Cosmetic outcome of post-operative wound | 4.39 | 0.89 | |
| Post-discharge | Post-discharge time to recovery | 4.48 | 0.88 |
| Post-discharge pain related to surgery | 4.57 | 0.76 | |
Fig. 4(left) Unmodified dental mouth gag. (right) Modified dental mouth gag used for mini laparotomy cholecystectomy